Avalanche Biotechnologies Lands $9,999,995 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=11cbe67d-fedf-4802-9afb-ff6f79b9707b
Date
9/8/2014
Company Name
Avalanche Biotechnologies
Mailing Address
1555 Adams Drive Menlo Park, CA 94025 USA
Company Description
Founded in 2006, Avalanche is a biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat wet age-related macular degeneration (AMD), as well as other ophthalmologic disorders, such as diabetic retinopathy, retinal degeneration, and glaucoma.
Website
http://www.avalanchebiotech.com
Transaction Type
Venture Equity
Transaction Amount
$9,999,995
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor